Hedge fund Elliott commands attention in C-suites as relentless activist
When Elliott Investment Management buys into a company to agitate for change, bankers and lawyers who have faced the hedge ...
Elliott Pushes Big Cost Cuts at BP to Preserve Its Independence
Elliott Investment Management is demanding BP Plc make drastic cost cuts and divestments to strengthen its future as a ...
Elliott builds BP stake of nearly 5%, pushes for big divestments, source says
Activist investor Elliott Management has built a near 5% stake in BP and is pushing the oil company to take radical action to transform its performance, including a big divestment programme, a source ...
News Highlights: Top Energy News of the Day - Friday at 12 AM ET
Oil futures tallied back-to-back session losses on Thursday, a day after President Donald Trump said that he and President Vladimir Putin of Russia had agreed to begin talks on ending the war in ...
Hosted on MSN23h
BP Stock In Spotlight After Report Says Elliott Acquires About $5B Stake, Aims To Push For Asset Sales: Retail Mood Brightens
BP Plc (BP) stock garnered retail attention premarket on Thursday after a report said activist investor Elliott has taken up ...
14 Press Releases You Need to See This Week
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
SelectQuote (SLQT) Gets a Hold from RBC Capital
RBC Capital analyst Ben Hendrix maintained a Hold rating on SelectQuote (SLQT – Research Report) on February 11 and set a price target of ...
Average US rate on a 30-year mortgage eases to 6.87%, fourth straight weekly decline
The average rate on a 30-year mortgage in the U.S. eased for the fourth week in a row, an encouraging sign for prospective ...
Trump signs a plan for reciprocal tariffs on US trading partners, ushering in economic uncertainty
WASHINGTON (AP) — President Donald Trump on Thursday rolled out his plan to increase U.S. tariffs to match the tax rates that ...
Travere Therapeutics price target raised to $32 from $27 at Scotiabank
Scotiabank analyst Greg Harrison raised the firm’s price target on Travere Therapeutics (TVTX) to $32 from $27 and keeps an Outperform rating on the shares. The company recently announced plans to ...
MarketWatch20h
Chevron Corp.
Petroleo Brasileiro S/A Ord 0.31% R$485.32B Petroleo Brasileiro S/A Pref-0.06% R$485.32B ...